| |
|
|
|
Celldex Therapeutics Inc.  
|
|
12.43 -0.95 (-0.07%) |
07-02 16:00 |
|
Open: |
13.64 |
Pre close: |
13.38 |
Target:
|
16.25
|
|
High: |
13.78 |
Low: |
12.27 |
Resistance:
|
13.91
16.25
|
|
Volume: |
733,903 |
Market Cap: |
483M |
Support:
|
6.84
2.47
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
12.53
 |
MACD |
MACD(12,26):
|
2.64 |
|
MA(20): |
8.02  |
Signal(12,26,9): |
2.25 |
|
MA(100): |
3.39 |
Stochastic Oscillator |
%K(14,3):
|
87.76 |
|
MA(250): |
2.75 |
%D(3): |
86.97 |
|
Average Volume(K) |
3-Month: |
284258
|
52-Week |
High:
|
13.91 |
|
10-Days: |
382297 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
75.27 |
Change(%): |
366.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.930 |
Return on Equity (ttm) |
-47.1 |
Shares Out. (M) |
38.83 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-25.3 |
Shares Float (M) |
17.91 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.19 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
91.4 |
% Held by Institutions |
23.25 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-1.007 |
Shares Short (K) |
2310 |
|
Book Value (p.s.) |
4.720 |
EBITDA (p.s.) |
-1.233 |
P/E |
-4.28 |
|
Sales Per Share |
0.126 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-45.29 |
P/S |
99.86 |
|
Operating Margin |
-1077.44 |
Levered Free Cash Flow
(M) |
-23.92 |
P/CF |
-10.76 |
|
|
|
|
|
|
